Particularly, H3Cit, MPO, MPO-DNA, NE, nucleosomes, and DNA, which are deemed as NETs biomarkers, have been evaluated in VTE, CAD, IS, cancer-associated thromboembolism, and COVID-19 associated thromboembolism (Fig. 2). Here, MPO is linked to coronary artery disorder.